Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q1

3353.TEDINET S100REIO
Period2023-03-01 → 2023-05-31
Filed2023-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.7bn2023-03-01 → 2023-05-31Cons.Net sales
Revenue¥33.9bn2022-03-01 → 2023-02-28Cons.Net sales (5-year summary)
Revenue¥8.6bn2022-03-01 → 2022-05-31Cons.Net sales
Operating income¥294m2023-03-01 → 2023-05-31Cons.Operating income
Operating income¥239m2022-03-01 → 2022-05-31Cons.Operating income
Ordinary income¥338m2023-03-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥1.2bn2022-03-01 → 2023-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥313m2022-03-01 → 2022-05-31Cons.Ordinary income
Profit before tax¥375m2023-03-01 → 2023-05-31Cons.Income before income taxes
Profit before tax¥334m2022-03-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)¥212m2023-03-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥760m2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥208m2022-03-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income¥224m2023-03-01 → 2023-05-31Cons.Profit loss
Net income¥213m2022-03-01 → 2022-05-31Cons.Profit loss
Total assets¥28.1bnat 2023-05-31Cons.Assets
Total assets¥27.5bnat 2023-02-28Cons.Assets
Total assets¥28.8bnat 2022-05-31Cons.Total assets (5-year summary)
Total liabilities¥15.4bnat 2023-05-31Cons.Liabilities
Total liabilities¥14.9bnat 2023-02-28Cons.Liabilities
Net assets / equity¥12.7bnat 2023-05-31Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥12.0bnat 2022-05-31Cons.Net assets (5-year summary)
Cash and deposits¥6.7bnat 2023-05-31Cons.Cash and deposits
Cash and deposits¥6.4bnat 2023-02-28Cons.Cash and deposits
EPS (basic)¥56.422023-03-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥202.22022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥55.392022-03-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.2%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio43.8%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio39.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-03-01 → 2023-05-31−¥277m
Reconciling Itemsreconcilingrevenue intersegment2023-03-01 → 2023-05-31−¥277m
Reconciling Itemsreconcilingsegment profit2023-03-01 → 2023-05-31−¥187m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2023-03-01 → 2023-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2023-03-01 → 2023-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2023-03-01 → 2023-05-31¥375m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2023-03-01 → 2023-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2023-03-01 → 2023-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2023-03-01 → 2023-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2023-03-01 → 2023-05-31¥50m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2023-03-01 → 2023-05-31¥1.1bn
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2023-03-01 → 2023-05-31¥810m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2023-03-01 → 2023-05-31¥275m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2023-03-01 → 2023-05-31¥23m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2023-03-01 → 2023-05-31¥47m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2023-03-01 → 2023-05-31¥46m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2023-03-01 → 2023-05-31¥1m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2023-03-01 → 2023-05-31¥34m
Total Of Reportable Segments And Otherssegment totalrevenue2023-03-01 → 2023-05-31¥9.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-03-01 → 2023-05-31¥8.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-03-01 → 2023-05-31¥277m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-03-01 → 2023-05-31¥481m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-05-31−¥189m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-05-31¥363m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-05-31¥19m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-05-31¥946m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-05-31¥694m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥252m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-05-31¥16m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥381,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-05-31¥30m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-05-31¥8.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-05-31¥253m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-05-31¥428m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 355
ItemContextValueUnit
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember150000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember275231000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember1163000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember276545000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-276545000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember5910452000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember1955243000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember1085664000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember47137000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember8998498000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-276545000JPY
Net salesCurrentYTDDuration8721952000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember374593000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember49876000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember22768000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember33731000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember480969000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-186566000JPY
Operating incomeCurrentYTDDuration294402000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東海財務局長
Filing date cover pageFilingDateInstant2023-07-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第39期第１四半期（自 2023年３月１日　至 2023年５月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社メディカル一光グループ
Company name in english cover pageFilingDateInstantMedical Ikkou Group Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　南野　利久
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)三重県津市西丸之内36番25号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)059－226－1193（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)上席執行役員　経理部・管理部担当　兼　財務・ＩＲ部長　遠山　邦彦
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)三重県津市西丸之内36番25号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)059－226－1193（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)上席執行役員　経理部・管理部担当　兼　財務・ＩＲ部長　遠山　邦彦
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE03443
Fund codeFilingDateInstant－
Security codeFilingDateInstant33530
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社メディカル一光グループ
Filer name in englishFilingDateInstantMedical Ikkou Group Co.,Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2023-03-01
Current period end dateFilingDateInstant2023-05-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-02-28pass
balance sheet identityconsolidated 2023-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2023-05-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-05-31pass
statement vs summary · revenueconsolidated 2023-03-01/2023-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2023-05-31pass